SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-048052
Filing Date
2015-02-13
Accepted
2015-02-13 06:11:00
Documents
2
Group Members
ABERDARE GP III, L.L.C.ABERDARE PARTNERS III, L.P.PAUL H. KLINGENSTEIN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d873550dsc13ga.htm SC 13G/A 89081
2 EX-A d873550dex99a.htm EX-99.A 4830
  Complete submission text file 0001193125-15-048052.txt   95607
Mailing Address ONE EMBARCADERO CENTER STE 4000 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER STE 4000 SAN FRANCISCO CA 94111 415-392-7442
Aberdare Ventures III LP (Filed by) CIK: 0001313414 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Subject) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87858 | Film No.: 15608847
SIC: 2834 Pharmaceutical Preparations